Product Information
ACETAMINOPHEN ER 650 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0631 per EA under NDC 68001049500. Its NADAC has been published 247 times since Oct 6, 2021.
Strength
650 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001049500
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHENApproval Type
Generic (ANDA)
FDA Application
ANDA207229On Market Since
4/30/2021
Price Statistics
The NADAC for ACETAMINOPHEN ER 650 MG TABLET has been published 247 times since Oct 6, 2021, and over the history we have for it it has declined 10.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0631 per EA |
|---|---|
| All-time high | $0.0759 (Mar 15, 2023) |
| All-time low | $0.0610 (May 22, 2024) |
| 52-week high | $0.0686 |
| 52-week low | $0.0631 |
| Median price | $0.0685 |
| Average price | $0.0679 |
| Largest weekly change | +16.2% (Feb 22, 2023) |
| Weeks tracked | 247 |
| Tracking since | Oct 6, 2021 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN ER 650 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN ER 650 MG TABLET, manufactured by BluePoint Laboratories, is $0.0631 per EA (NDC 68001049500), effective Jun 24, 2026.
How has the price of ACETAMINOPHEN ER 650 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN ER 650 MG TABLET has declined 10.3%. It has been tracked across 247 weekly CMS publications since Oct 6, 2021.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN ER 650 MG TABLET?
Since Oct 6, 2021, the NADAC for ACETAMINOPHEN ER 650 MG TABLET has ranged from a low of $0.0610 (May 22, 2024) to a high of $0.0759 (Mar 15, 2023), with a median of $0.0685 per EA.
Are there cheaper alternatives to ACETAMINOPHEN ER 650 MG TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QC ARTHRITIS PAIN ER 650 MG, is $0.0599 per EA — about 5% below ACETAMINOPHEN ER 650 MG TABLET.
Who manufactures ACETAMINOPHEN ER 650 MG TABLET?
ACETAMINOPHEN ER 650 MG TABLET (NDC 68001049500) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification